男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Sinopharm wins approval for inhaled Omicron antibody trials

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2022-11-28 19:41
Share
Share - WeChat

Chinese drugmaker Sinopharm said on Monday it has obtained approval to conduct clinical trials of an inhaled monoclonal antibody against the novel coronavirus, a potentially significant weapon against the dominant Omicron variant.

China National Biotech Group, a subsidiary of Sinopharm, received authorization from the National Medical Products Administration on Friday to test a nasal spray utilizing a monoclonal antibody, F61, as a preventive therapy for personnel at high risk of exposure to the virus, according to a statement released by the company.

F61 has demonstrated wide-spectrum neutralizing activities against the original virus and its major strains, including dominant variants in circulation, such as Omicron BA.1, BA.1 .1, BA.2, BA.3, BA.4/5 and BF.7, it said.

An injection version of F61 was approved for human trials on July 22. The first phase of the trial, initiated in Hangzhou on July 28, is near completion, and results have shown a good safety record.

The F61 inhaled spray is easier to use and is expected to trigger protection along nasal mucosa, the first line of defense against respiratory pathogens like the novel coronavirus.

It added the drug candidate has been shown to be safe and effective in real-world studies, and can reduce the rate of infection among close contacts.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 禄丰县| 崇州市| 黔东| 延长县| 崇礼县| 郴州市| 武宁县| 呼和浩特市| 佛坪县| 长垣县| 顺义区| 尼木县| 涞水县| 闵行区| 巩义市| 南雄市| 宾川县| 垦利县| 方城县| 涟源市| 定安县| 巴塘县| 山丹县| 西安市| 会宁县| 永嘉县| 嘉善县| 阿瓦提县| 宿州市| 岳西县| 肥西县| 绥芬河市| 左贡县| 石泉县| 长顺县| 丹寨县| 平乐县| 攀枝花市| 连云港市| 武宁县| 平利县|